Annual Accounts Receivable
$249.37 M
+$34.98 M+16.31%
31 December 2022
Summary:
NuVasive annual accounts receivable is currently $249.37 million, with the most recent change of +$34.98 million (+16.31%) on 31 December 2022. During the last 3 years, it has risen by +$34.98 million (+16.31%).NUVA Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$267.11 M
+$17.08 M+6.83%
30 June 2023
Summary:
NuVasive quarterly accounts receivable is currently $267.11 million, with the most recent change of +$17.08 million (+6.83%) on 30 June 2023.NUVA Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NUVA Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +16.3% | +24.6% |
| 5 y5 years | +17.9% | +26.3% |
NUVA Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | at high | at high |
NuVasive Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $267.11 M(+6.8%) |
| Mar 2023 | - | $250.02 M(+0.3%) |
| Dec 2022 | $249.37 M(+16.3%) | $249.37 M(+5.9%) |
| Sept 2022 | - | $235.58 M(+0.9%) |
| June 2022 | - | $233.57 M(+0.9%) |
| Mar 2022 | - | $231.43 M(+7.9%) |
| Dec 2021 | $214.40 M(+3.5%) | $214.40 M(+7.5%) |
| Sept 2021 | - | $199.37 M(-8.1%) |
| June 2021 | - | $216.91 M(+5.8%) |
| Mar 2021 | - | $205.03 M(-1.0%) |
| Dec 2020 | $207.07 M(-2.1%) | $207.07 M(+0.9%) |
| Sept 2020 | - | $205.25 M(+12.7%) |
| June 2020 | - | $182.13 M(-2.5%) |
| Mar 2020 | - | $186.83 M(-11.7%) |
| Dec 2019 | $211.53 M(+7.7%) | $211.53 M(+3.9%) |
| Sept 2019 | - | $203.61 M(-2.1%) |
| June 2019 | - | $207.99 M(+7.0%) |
| Mar 2019 | - | $194.36 M(-1.1%) |
| Dec 2018 | $196.49 M(-1.9%) | $196.49 M(+2.6%) |
| Sept 2018 | - | $191.57 M(-4.2%) |
| June 2018 | - | $199.91 M(+6.3%) |
| Mar 2018 | - | $188.11 M(-6.0%) |
| Dec 2017 | $200.22 M(+16.7%) | $200.22 M(+6.9%) |
| Sept 2017 | - | $187.25 M(-1.5%) |
| June 2017 | - | $190.17 M(+10.5%) |
| Mar 2017 | - | $172.10 M(+0.3%) |
| Dec 2016 | $171.59 M(+34.5%) | $171.59 M(+19.3%) |
| Sept 2016 | - | $143.82 M(+1.3%) |
| June 2016 | - | $141.92 M(+12.6%) |
| Mar 2016 | - | $126.09 M(-1.2%) |
| Dec 2015 | $127.59 M(+7.3%) | $127.59 M(+10.4%) |
| Sept 2015 | - | $115.58 M(-1.1%) |
| June 2015 | - | $116.83 M(+4.7%) |
| Mar 2015 | - | $111.55 M(-6.2%) |
| Dec 2014 | $118.96 M(+13.5%) | $118.96 M(+9.8%) |
| Sept 2014 | - | $108.37 M(-3.7%) |
| June 2014 | - | $112.57 M(+5.9%) |
| Mar 2014 | - | $106.27 M(+1.4%) |
| Dec 2013 | $104.77 M | $104.77 M(+8.9%) |
| Sept 2013 | - | $96.21 M(-0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2013 | - | $96.31 M(+6.5%) |
| Mar 2013 | - | $90.41 M(+1.6%) |
| Dec 2012 | $88.96 M(+1.4%) | $88.96 M(+13.8%) |
| Sept 2012 | - | $78.14 M(-8.9%) |
| June 2012 | - | $85.75 M(+0.2%) |
| Mar 2012 | - | $85.57 M(-2.5%) |
| Dec 2011 | $87.74 M(+14.5%) | $87.74 M(+11.6%) |
| Sept 2011 | - | $78.64 M(-2.4%) |
| June 2011 | - | $80.53 M(+6.0%) |
| Mar 2011 | - | $75.95 M(-0.9%) |
| Dec 2010 | $76.63 M(+31.1%) | $76.63 M(+7.0%) |
| Sept 2010 | - | $71.62 M(+5.0%) |
| June 2010 | - | $68.23 M(+9.7%) |
| Mar 2010 | - | $62.19 M(+6.4%) |
| Dec 2009 | $58.46 M(+13.3%) | $58.46 M(+14.1%) |
| Sept 2009 | - | $51.24 M(+5.6%) |
| June 2009 | - | $48.53 M(-3.0%) |
| Mar 2009 | - | $50.03 M(-3.1%) |
| Dec 2008 | $51.62 M(+87.7%) | $51.62 M(+12.0%) |
| Sept 2008 | - | $46.07 M(+41.6%) |
| June 2008 | - | $32.53 M(+7.2%) |
| Mar 2008 | - | $30.34 M(+10.3%) |
| Dec 2007 | $27.50 M(+45.0%) | $27.50 M(+13.0%) |
| Sept 2007 | - | $24.33 M(+4.6%) |
| June 2007 | - | $23.26 M(+8.3%) |
| Mar 2007 | - | $21.48 M(+13.3%) |
| Dec 2006 | $18.96 M(+62.6%) | $18.96 M(+26.2%) |
| Sept 2006 | - | $15.03 M(+9.3%) |
| June 2006 | - | $13.74 M(+12.4%) |
| Mar 2006 | - | $12.23 M(+4.9%) |
| Dec 2005 | $11.66 M(+72.3%) | $11.66 M(+23.3%) |
| Sept 2005 | - | $9.46 M(+4.3%) |
| June 2005 | - | $9.07 M(+14.9%) |
| Mar 2005 | - | $7.89 M(+16.6%) |
| Dec 2004 | $6.77 M(+81.6%) | $6.77 M(+21.5%) |
| Sept 2004 | - | $5.57 M(+13.4%) |
| June 2004 | - | $4.91 M(+21.4%) |
| Mar 2004 | - | $4.05 M |
| Dec 2003 | $3.73 M(+95.4%) | - |
| Dec 2002 | $1.91 M | - |
FAQ
- What is NuVasive annual accounts receivable?
- What is the all time high annual accounts receivable for NuVasive?
- What is NuVasive quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for NuVasive?
What is NuVasive annual accounts receivable?
The current annual accounts receivable of NUVA is $249.37 M
What is the all time high annual accounts receivable for NuVasive?
NuVasive all-time high annual accounts receivable is $249.37 M
What is NuVasive quarterly accounts receivable?
The current quarterly accounts receivable of NUVA is $267.11 M
What is the all time high quarterly accounts receivable for NuVasive?
NuVasive all-time high quarterly accounts receivable is $267.11 M